Critical role for conversion of glu-plasminogen to Lys-plasminogen for optimal stimulation of plasminogen activation on cell surfaces.
暂无分享,去创建一个
[1] M. Ranson,et al. The topology of plasminogen binding and activation on the surface of human breast cancer cells , 2001, British Journal of Cancer.
[2] F. Castellino,et al. Conversion of Glu-Plasminogen to Lys-Plasminogen Is Necessary for Optimal Stimulation of Plasminogen Activation on the Endothelial Cell Surface* , 2001, The Journal of Biological Chemistry.
[3] L. Miles,et al. Purification, Cloning, and Characterization of a Profibrinolytic Plasminogen-binding Protein, TIP49a* , 2001, The Journal of Biological Chemistry.
[4] D. O'Connor,et al. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion. , 2000, The Journal of clinical investigation.
[5] M. Boyle,et al. The interaction of pathogens with humans. , 2000, Methods.
[6] Jordi Félez,et al. Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87). , 1999, Blood.
[7] V. Sinniger,et al. Regulation of Tissue Plasminogen Activator Activity by Cells , 1999, The Journal of Biological Chemistry.
[8] V. Fischetti,et al. α-Enolase, a Novel Strong Plasmin(ogen) Binding Protein on the Surface of Pathogenic Streptococci* , 1998, The Journal of Biological Chemistry.
[9] F. Castellino,et al. Activation of human plasminogen by staphylokinase. Direct evidence that preformed plasmin is necessary for activation to occur. , 1997, Blood.
[10] P. Ganz,et al. ENDOTHELIAL CELL SURFACE ACTIN SERVES AS A BINDING SITE FOR PLASMINOGEN, TISSUE PLASMINOGEN ACTIVATOR AND LIPOPROTEIN(a) , 1996, British journal of haematology.
[11] R. Lottenberg,et al. The plasmin-binding protein Plr of group A streptococci is identified as glyceraldehyde-3-phosphate dehydrogenase. , 1996, Microbiology.
[12] A. Horrevoets,et al. The Activation-resistant Conformation of Recombinant Human Plasminogen Is Stabilized by Basic Residues in the Amino-terminal Hinge Region (*) , 1995, The Journal of Biological Chemistry.
[13] S. L. Gonias,et al. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. , 1995, Journal of cell science.
[14] Kanefusa Kato,et al. Plasminogen Binds Specifically to α‐Enolase on Rat Neuronal Plasma Membrane , 1994 .
[15] M. Parmely,et al. Regulation of plasminogen activation by human U937 promonocytic cells. , 1994, The Journal of biological chemistry.
[16] K. Hajjar,et al. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. , 1994, The Journal of biological chemistry.
[17] R. López-Alemany,et al. Purification of the plasmin receptor from human carcinoma cells and comparison to α-enolase , 1994 .
[18] H. Rauvala,et al. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. , 1993, The Journal of biological chemistry.
[19] M. Nesheim,et al. Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro. , 1992, The Journal of biological chemistry.
[20] B. Schwartz,et al. Single chain urokinase. Augmentation of enzymatic activity upon binding to monocytes. , 1991, The Journal of biological chemistry.
[21] K. Danø,et al. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. , 1991, The Journal of biological chemistry.
[22] K. Danø,et al. Plasminogen Activation by Receptor-Bound Urokinase , 1991, Seminars in thrombosis and hemostasis.
[23] S. Pizzo,et al. Plasmin binding to the plasminogen receptor enhances catalytic efficiency and activates the receptor for subsequent ligand binding. , 1991, Archives of biochemistry and biophysics.
[24] Jordi Félez,et al. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. , 1991, Biochemistry.
[25] T. Rapoport,et al. A novel pathway for secretory proteins? , 1990, Trends in biochemical sciences.
[26] E. Plow,et al. Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells. , 1989, Biochemistry.
[27] M. Scully,et al. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. , 1989, The Journal of biological chemistry.
[28] K. Hajjar,et al. Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface. , 1988, The Journal of clinical investigation.
[29] S. Thorsen,et al. The course and prerequisites of Lys-plasminogen formation during fibrinolysis. , 1988, Biochemistry.
[30] J. Piatigorsky,et al. Recruitment of enzymes as lens structural proteins. , 1987, Science.
[31] J. Loscalzo,et al. Tissue plasminogen activator promotes platelet disaggregation in plasma. , 1987, The Journal of clinical investigation.
[32] J. Plescia,et al. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type , 1986, The Journal of cell biology.
[33] E. Jaffe,et al. Binding of plasminogen to cultured human endothelial cells. , 1986, The Journal of biological chemistry.
[34] D. T. Shiu,et al. Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation. , 1986, Blood.
[35] J. White,et al. Plasminogen interacts with human platelets through two distinct mechanisms. , 1986, The Journal of clinical investigation.
[36] D. Collen,et al. A monoclonal antibody specific for Lys-plasminogen. Application to the study of the activation pathways of plasminogen in vivo. , 1985, The Journal of biological chemistry.
[37] E. Plow,et al. Binding and activation of plasminogen on the platelet surface. , 1985, The Journal of biological chemistry.
[38] M. Hoylaerts,et al. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. , 1982, The Journal of biological chemistry.
[39] R. Priore,et al. The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation. , 1979, The Journal of biological chemistry.
[40] G. Markus,et al. Comparison of some properties of native (Glu) and modified (Lys) human plasminogen. , 1978, The Journal of biological chemistry.
[41] G. Markus,et al. Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogen. , 1978, The Journal of biological chemistry.
[42] B. Violand,et al. Mechanism of the urokinase-catalyzed activation of human plasminogen. , 1976, The Journal of biological chemistry.
[43] T. Astrup,et al. Reversible and Irreversible Alterations of Human Plasminogen Indicated by Changes in Susceptibility to Plasminogen Activators and in Response to ∈-Aminocaproic Acid , 1974, Thrombosis and Haemostasis.
[44] T. Astrup,et al. Substrate Composition and the Effect of ε-Aminocaproic Acid on Tissue Plasminogen Activator and Urokinase-induced Fibrinolysis , 1974, Thrombosis and Haemostasis.
[45] S. Thorsen,et al. Rate of activation and electrophoretic mobility of unmodified and partially degraded plasminogen. Effects of 6-aminohexanoic acid and related compounds. , 1974, Scandinavian journal of clinical and laboratory investigation.
[46] J. Vermylen,et al. Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid. , 1974, Biochimica et biophysica acta.
[47] B. Wiman. Primary structure of peptides released during activation of human plasminogen by urokinase. , 1973, European journal of biochemistry.
[48] B. Wiman,et al. Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound. , 1973, European journal of biochemistry.
[49] Jordi Félez,et al. Characterization of Cellular Binding Sites and Interactive Regions within Reactants Required for Enhancement of Plasminogen Activation by tPA on the Surface of Leukocytic Cells , 1996, Thrombosis and Haemostasis.
[50] E. Plow,et al. The role of an enolase-related molecule in plasminogen binding to cells. , 1995, European journal of biochemistry.
[51] B. Wiman,et al. Structural relationship between "glutamic acid" and "lysine" forms of human plasminogen and their interaction with the NH2-terminal activation peptide as studied by affinity chromatography. , 1975, European journal of biochemistry.
[52] B. Violand,et al. The effect of ϵ-amino caproic acid on the gross conformation of plasminogen and plasmin , 1975 .